RGD Reference Report - Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Transcription factor RUNX2 up-regulates chemokine receptor CXCR4 to promote invasive and metastatic potentials of human gastric cancer.

Authors: Guo, Zheng-Jun  Yang, Lang  Qian, Feng  Wang, Yan-Xia  Yu, Xi  Ji, Cheng-Dong  Cui, Wei  Xiang, Dong-Fang  Zhang, Xia  Zhang, Peng  Wang, Ji Ming  Cui, You-Hong  Bian, Xiu-Wu 
Citation: Guo ZJ, etal., Oncotarget. 2016 Apr 12;7(15):20999-1012. doi: 10.18632/oncotarget.8236.
RGD ID: 152023648
Pubmed: PMID:27007162   (View Abstract at PubMed)
PMCID: PMC4991507   (View Article at PubMed Central)
DOI: DOI:10.18632/oncotarget.8236   (Journal Full-text)

Runt-related transcription factor 2 (RUNX2) is a regulator of embryogenesis and development, but has also been implicated in the progression of certain human cancer. This study aimed to elucidate the role of RUNX2 in the invasive and metastatic potentials of human gastric cancer (GC) and the underlying mechanisms. We found that the levels of RUNX2 expression in gastric cancer tissues were correlated with the differentiation degrees, invasion depth and lymph node metastasis. COX regression analysis indicated that RUNX2 was an independent prognostic indicator for GC patients. RUNX2 significantly increased the migration and invasion ability of GC cells in vitro and enhanced the invasion and metastatic potential of GC cells in an orthotopic GC model of nude mice. Mechanistically, RUNX2 directly bound to the promoter region of the gene coding for the chemokine receptor CXCR4 to enhance its transcription. CXCR4 knockdown or treatment with AMD3100, a CXCR4 inhibitor, attenuated RUNX2-promoted invasion and metastasis. These results demonstrate that RUNX2 promotes the invasion and metastasis of human GC by transcriptionally up-regulating the chemokine receptor CXCR4. Therefore, the RUNX2-CXCR4 axis is a potential therapeutic target for GC.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
stomach cancer amelioratesIMP 152023648human cells in mouse modelRGD 
stomach cancer amelioratesISOCXCR4 (Homo sapiens)152023648; 152023648human cells in mouse modelRGD 

Objects Annotated

Genes (Rattus norvegicus)
Cxcr4  (C-X-C motif chemokine receptor 4)

Genes (Mus musculus)
Cxcr4  (C-X-C motif chemokine receptor 4)

Genes (Homo sapiens)
CXCR4  (C-X-C motif chemokine receptor 4)


Additional Information